Astera Labs (NASDAQ:ALAB) Director Sells $3,276,963.90 in Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $3,276,963.90. Following the completion of the sale, the director directly owned 5,292 shares in the company, valued at approximately $1,928,140.20. The trade was a 62.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Trading Down 11.4%

Shares of NASDAQ ALAB traded down $40.99 on Friday, reaching $317.06. 7,300,593 shares of the company traded hands, compared to its average volume of 5,546,898. The stock has a market capitalization of $54.35 billion, a PE ratio of 214.23, a P/E/G ratio of 4.81 and a beta of 3.95. Astera Labs, Inc. has a fifty-two week low of $84.78 and a fifty-two week high of $372.37. The company has a 50 day moving average of $209.01 and a 200 day moving average of $170.57.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the company earned $0.33 earnings per share. The company’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Royal Bank of Canada grew its holdings in Astera Labs by 167.3% during the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC boosted its position in Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC boosted its position in Astera Labs by 917.3% in the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the last quarter. First Trust Advisors LP grew its stake in shares of Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after acquiring an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. grew its stake in shares of Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares in the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ALAB. Royal Bank Of Canada increased their target price on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Roth Mkm reissued a “buy” rating and set a $275.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Loop Capital started coverage on Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 price target for the company. Evercore restated an “outperform” rating and issued a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Finally, UBS Group initiated coverage on Astera Labs in a report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 target price for the company. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.